Vaccitech Newsroom

Newsroom

News & updates

Vaccitech Appoints Bill Enright as New Chief Executive Officer

Vaccitech, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases (ID), announced today that it has appointed Bill Enright as its new Chief Executive Officer (CEO). Mr. Enright succeeds Tom Evans, MD who...

Vacancy: Clinical Study Manager

To manage and maintain oversight for all study activities allocated. This will involve team leadership, management of clinical sites and vendors, budgeting, adherence to internal SOPs, ICH GCP and applicable regulations as well as other tasks relevant to coordinating...

Update: INVICTUS Study

Vaccitech has taken the decision not to proceed with season 2 of the current FLU007 (Invictus) study due to the changes recommended by the UK Government which directed the NHS to use FLUAD (adjuvanted TIV) vaccine in the 65 year old and over population in the 2018/19...